Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Omega-3 Fatty Acids in Psychiatry: A Review

Omega-3 Fatty Acids in Psychiatry: A Review Omega-3 fatty acids are long-chain, polyunsaturated fatty acids found in plant and marine sources. Unlike saturated fats, which have been shown to have negative health consequences, omega-3 fatty acids are polyunsaturated fatty acids that have been associated with many health benefits. Omega-3 fatty acids may prove to be efficacious in a number of psychiatric disorders. Mood disorders have been associated with abnormalities in fatty acid composition. Several lines of evidence suggest that diminished omega-3 fatty acid concentrations are associated with mood disorders. Clinical data are not yet available regarding omega-3 fatty acids in the treatment of major depression. However, one double-blind treatment trial has been conducted in bipolar disorder. Also, substantial evidence does exist supporting a potential role of omega-3 fatty acids in schizophrenia, although treatment data are needed. A case has been reported in which a patient with schizophrenia was successfully treated with omega-3 fatty acids. Controlled studies are necessary to explore the potential treatment of schizophrenia with omega-3 fatty acids. Omega-3 fatty acids may also be helpful in the treatment of dementia. Furthermore, omega-3 fatty acids may prove to be a safe and efficacious treatment for psychiatric disorders in pregnancy and in breastfeeding. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Clinical Psychiatry Springer Journals

Omega-3 Fatty Acids in Psychiatry: A Review

Freeman, Marlene
Annals of Clinical Psychiatry , Volume 12 (3) – Oct 8, 2004
Download PDF
7 pages

Loading next page...
 
/lp/springer-journals/omega-3-fatty-acids-in-psychiatry-a-review-F04IYrI1Fn
Publisher
Springer Journals
Copyright
Copyright © 2000 by American Academy of Clinical Psychiatrists
Subject
Medicine & Public Health; Neurology; Psychiatry; Psychopharmacology
ISSN
1040-1237
eISSN
1573-3238
DOI
10.1023/A:1009069002816
Publisher site
See Article on Publisher Site

Abstract

Omega-3 fatty acids are long-chain, polyunsaturated fatty acids found in plant and marine sources. Unlike saturated fats, which have been shown to have negative health consequences, omega-3 fatty acids are polyunsaturated fatty acids that have been associated with many health benefits. Omega-3 fatty acids may prove to be efficacious in a number of psychiatric disorders. Mood disorders have been associated with abnormalities in fatty acid composition. Several lines of evidence suggest that diminished omega-3 fatty acid concentrations are associated with mood disorders. Clinical data are not yet available regarding omega-3 fatty acids in the treatment of major depression. However, one double-blind treatment trial has been conducted in bipolar disorder. Also, substantial evidence does exist supporting a potential role of omega-3 fatty acids in schizophrenia, although treatment data are needed. A case has been reported in which a patient with schizophrenia was successfully treated with omega-3 fatty acids. Controlled studies are necessary to explore the potential treatment of schizophrenia with omega-3 fatty acids. Omega-3 fatty acids may also be helpful in the treatment of dementia. Furthermore, omega-3 fatty acids may prove to be a safe and efficacious treatment for psychiatric disorders in pregnancy and in breastfeeding.

Journal

Annals of Clinical Psychiatry – Springer Journals

Published: Oct 8, 2004

References

  • Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey
    Eisenberg, DM; Davis, RB; Ettner, SL; Appel, S; Wilkey, S; Van Rompay, M; Kessler, RC
  • Use of Alternative therapies among emergency department patients
    Gulla, J; Singer, AJ
  • Why patients use alternative medicine: results of a national study
    Astin, JA
  • Does fish oil lower blood pressure? A meta-analysis of controlled trials
    Morris, MC; Sacks, F; Rosner, B
  • Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease
    Belluzzi, A; Brignola, C; Campieri, M; Pera, A; Boschi, S; Miglioli, M
  • Effects of high dose fish oil on rheumatoid arthritis after stopping nonsteroidal antiinflammatory drugs
    Kremer, JM; Lawrence, DA; Petrillo, GF; Litts, LL; Mullaly, PM; Rynes, RI; Stocker, RP; Parhami, N; Greenstein, NS; Fuchs, BR
  • Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production
    Broughton, KS; Johnson, CS; Pace, BK; Liebman, M; Kleppinger, KM
  • Dietary intake and cell membrane levels and the risk of primary cardiac arrest
    Siscovick, DS; Raghunathun, TE; King, I; Weinmann, S; Wicklund, KG; Albright, J; Bovbjerg, V; Arbogast, P; Smith, H; Rushi, LH
  • Prospective assessment of coronary heart disease risk factors: the NHANES I epidemiologic follow-up study (NHEFS) 16-year follow-up
    Gartside, PS; Wang, P; Glueck, CJ
  • Prolonged inhibition of platelet aggregation after n-3 fatty acid ethyl ester ingestion by healthy volunteers
    Tremoli, E; Maderna, P; Marangoni, F; Colli, S; Eligini, S; Catalano, I; Angeli, MT; Pazzucconi, F; Gianfranceschi, G; Davi, G
  • Breast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms
    Ambrosone, CB; Freudenheim, JL; Sinha, R; Graham, S; Marshall, JR; Vena, JE; Laughlin, R; Nemoto, T; Shields, PG
  • Dietary fat intake and risk of lung cancer: a prospective study of 51,452 Norwegian men and women
    Veierod, MB; Laake, P; Thelle, DS
  • Deficiency of essential fatty acids and membrane fluidity during pregnancy and lactation
    Holman, RT; Johnson, SB; Ogburn, PL
  • Fish consumption and major depression
    Hibbeln, JR
  • Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients
    Peet, M; Murphy, B; Shay, J; Horrobin, D
  • Fatty acid composition in major depression: decreased omega-3 fractions idn cholesteryl esters and increased C20:4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and Phospholipids
    Maes, M; Smith, R; Christophe, A; Cosyns, P; Desnyder, R; Meltzer, H
  • Arachadonic acid to eicosapentaenoic acid ration in blood correlates positively with clinical symptoms of depression
    Adams, PB; Lawson, S; Sanigorski, A; Sinclair, AJ
  • Omega-3 polyunsaturated fatty acids in the diet and in the red blood cell membranes of depressed patients
    Edwards, R; Peet, M; Shay, J; Horrobin, D
  • Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early-and late-onset alcoholics
    Hibbeln, JR; Linnoila, M; Umhau, JC; Rawlings, R; George, DT; Salem, N
  • A replication study of violent and nonviolent subjects: cerebrospinal fluid metabolites of serotonin and dopamine are predicted by plasma essential fatty acids
    Hibbeln, JR; Umhau, JC; Linnoila, M; George, DT; Ragan, PW; Shoaf, SE; Vaughan, MR; Rawlings, R; Salem, N
  • Significantly increased expression of Tcell activation markers (interleukin-2 and HLA-DR) in depression: further evidence for an inflammatory process during that illness
    Maes, M; Stevens, WJ; Declerck, LS; Bridts, CH; Peeters, D; Schotte, C; Cosyns, P
  • The macrophage theory of depression
    Smith, RS
  • Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers
    Maes, M; Bosmans, E; Calabrese, J; Smith, R; Meltzer, HY
  • Acute phase proteins in schizophrenia, mania, and major depression: modulation by psychotropic drugs
    Maes, M; Delange, J; Ranjan, R; Meltzer, HY; Desnyder, R; Cooremans, W; Scharpe, S
  • The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression
    Song, C; Lin, A; Bonaccorso, S; Heide, C; Verkerk, R; Kenis, G; Bosmans, E; Sharpe, S; Whelan, A; Cosyns, P; de Jongh, R; Maes, M
  • Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response
    Maes, M; Verkerk, R; Vandoolaeghe, E; Van Hunsel, F; Neels, H; Wauters, A; Demedts, P.; Scharpe, S
  • Effect of n-3 polyunsaturated fatty acids on cytokine production and their biologic function
    Meydani, SN
  • n-3 polyunsaturated fatty acids and human cytokine synthesis
    Endres, S
  • N-3 polyunsaturated fatty acids and cytokine production in health and disease
    Calder, PC
  • Docosahexanoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6
    Khalfoun, B; Thibault, F; Watier, H; Bardos, P; Lebranchu, Y
  • Effect of eicosapentaenoic and docosahexaenoic acid on natural killer cell activity in human peripheral blood lymphocytes
    Yamashita, N; Maruyama, M; Yamazaki, K; Hamazaki, T; Yano, S
  • Afish oil diet rich in eicosapentanoic acid reduces cyclooxygenase metabolites, and suppresses lupus in MPL-1pr mice
    Kelly, VE; Ferretti, A; Izui, S
  • Dietary fish oil modulates macrophage fatty acids and decreases susceptibility in mice
    Leslie, CA; Gonnerman, WA; Ullman, MD
  • Lipids, membrane receptors, and enzymes: Effects of dietary fatty acids
    Kinsella, JE
  • Omega-3 fatty acids in bipolar disorder: a double-blind placebo-controlled trial
    Stoll, AL; Severus, E; Freeman, MP; Rueter, S; Zboyan, HA; Diamond, E; Cress, KK; Marangell, LB
  • Fat consumption and schizophrenia
    Christensen, O; Christensen, E
  • Depleted red cell membrane essential fatty acids in drugtreated schizophrenic patients
    Peet, M; Laugharne, J; Rangarajan, N; Horrobin, D; Reynolds, G
  • Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation
    Peet, M; Laugharne, JDE; Mellor, J; Ramchand, CN
  • Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation
    Peet, M; Laugharne, JDE; Mellor, J; Ramchand, CN
  • Essential fatty acid supplementation in tardive dyskinesia
    Wolkin, A; Jordan, B; Peselow, E; Rubinstein, M; Retrosen, J
  • A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia
    Vaddadi, KS; Courtney, P; Gilleard, CJ; Manku, MS; Horrobin, DF
  • A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases
    Glen, AI; Glen, EM; Horrobin, DF; Vaddadi, KS; Spellman, M; Morse-Fisher, N; Ellis, K; Skinner, FS
  • Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers
    Maes, M; Bosmans, E; Calabrese, J; Smith, R; Meltzer, HY
  • Acute phase proteins in schizophrenia, mania, and major depression: modulation by psychotropic drugs
    Maes, M; Delange, J; Ranjan, R; Meltzer, HY; Desnyder, R; Cooremans, W; Scharpe, S
  • Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs
    Maes, M; Bosmans, E; Ranjan, R; Vandoolaeghe, E; Meltzer, HY; De Ley, M; Berghmans, R; Stans, G; Desnyder, R
  • Effect of n-3 polyunsaturated fatty acids on cytokine production and their biologic function
    Meydani, SN
  • n-3 polyunsaturated fatty acids and human cytokine synthesis
    Endres, S
  • N-3 polyunsaturated fatty acids and cytokine production in health and disease
    Calder, PC
  • Docosahexanoic and eicosapentaenoic acids inhibit in vitro human endothelial cell production of interleukin-6
    Khalfoun, B; Thibault, F; Watier, H; Bardos, P; Lebranchu, Y
  • Effect of eicosapentaenoic and docosahexaenoic acid on natural killer cell activity in human peripheral blood lymphocytes
    Yamashita, N; Maruyama, M; Yamazaki, K; Hamazaki, T; Yano, S
  • Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition
    Yao, JK; van Kammen, DP; Welker, JA
  • Sustained Remission of positive and negative symptoms of schizophrenia following treatment with eicosapentaenoic acid
    Puri, BK; Steiner, R; Richardson, AJ
  • Regional membrane phospholipid altercations in Alzheimer's Disease
    Prasad, MR; Lovell, MA; Yatin, M; Dhillon, H; Markesbery, WR
  • Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content
    Corrigan, FM; Horrobin, DF; Skinner, ER; Besson, JAO; Cooper, MB
  • Dietary fat intake and the risk of incident dementia in the Rotterdam study
    Kalmijn, S; Launer, LJ; Ott, A; Witteman, JC; Hofman, A; Breteler, MM
  • Alzheimer's disease and omega-3 fatty acids: hypothesis
    Peers, RJ
  • Maternal and neonatal essential fatty acid status in phospholipids: an international comparative study
    Otto, SJ; Van Houwelingen, AC; Antal, M; Manninen, A; Godfrey, K; Lopez-Jaramillo, P; Hornstra, G
  • Essential fatty acids in pregnancy and early human development
    Hornstra, G; Al, DM; Van Houwelingen, AC; Foreman-van Drongelen, M
  • Phospholipid Spectrum Disorders in Psychiatry
    Hibbeln, JR
  • Essential fatty acid content of maternal erythrocyte phospholipids. A study in pertern and full-term human newborns
    Araya, J; Rojas, M; Fernandez, P; Matenluna, A
  • Randomised controlled trial of effect of fish oil supplementation on pregnancy duration
    Olsen, SF; Sorensen, JD; Secher, NJ; Hedegaard, M; Henriksen, TB; Hansen, HS; Grant, A
  • Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia
    Williams, MA; Zingham, RW; King, IB; Zebelman, AM
  • Diet during pregnancy and the risk of cerebral palsy
    Petridou, E; Koussouri, M; Toupadaki, N; Youroukos, S; Papavassiliou, A; Pantelakis, S; Olsen, J; Trichopoulos, D
  • Are n-3 fatty acids essential nutrients for fetal and infant development
    Nettleton, JA
  • Essentiality of dietary n-3 fatty acids for premature infants: plasma and red blood cell fatty acid composition
    Hoffman, DR; Uauy, R
  • Influence of feeding artificial-formula milks containing docohexaenoic and arachidonic acids on the postnatal long-chain polyunsaturated fatty acid status of healthy preterm infants
    Foreman-Van Drongelen, M; Van Houwelingen, AC; Kester, ADM; Blanco, CE; Hasaart, THM; Hornstra, G
  • Will dietary omega-3 fatty acids change the composition of breast milk
    Harris, WS; Connor, WE; Linsey, S
  • Interruption of vascular thrombus formation and vascular lesion formation by dietary omega-3 fatty acids in fish oil in nonhuman primates
    Harker, LA; Kelly, AB; Hanson, SR; Krupski, W; Bass, A; Osterud, B; Fitzgerald, GA; Goodnight, SC; Connor, WE.
  • Effects of dietary fat content, saturated fatty acids, and fish oil on eicosanoid production and hemostatic parameters in normal men
    Nordoy, A; Hatcher, L; Goodnight, S; Fitzgerald, DA; Conner, WE.
  • Delay in primary hemostasis produced by a fish diet without change in local thromboxane A2
    Thorngren, M; Shafi, S; Born, GVR.
  • Preliminary evidence of neurotoxicity associated with eating fish from the upper St. Lawrence River Lakes
    Mergler, D; Belanger, S; Larribe, F; Panisset, M; Bowler, R; Baldwin, M; Lebel, J; Hudnell, K
  • Profiles of Great Lakes critical pollutants: a sentinal analysis of human blood and urine. The Great Lakes Consortium
    Anderson, HA; Falk, C; Hanrahan, L; Olson, J; Burse, VW; Needham, L; Paschal, D; Patterson, D; Hill, RH